Filing Details

Accession Number:
0000899243-20-026691
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-01 17:52:17
Reporting Period:
2020-09-29
Accepted Time:
2020-10-01 17:52:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1320350 Lensar Inc. LNSR Biological Products, (No Disgnostic Substances) (2836) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
882104 Pdl Biopharma, Inc. 932 Southwood Boulevard
Incline Village NV 89451
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-29 8,703 $11.16 8,667,397 No 4 P Direct
Common Stock Disposition 2020-10-01 8,667,397 $0.00 0 No 4 J Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 J Direct
Footnotes
  1. In connection with the separation of the Issuer from the Reporting Person on October 1, 2020, the Reporting Person distributed all of the shares of common stock of the Issuer in the form of a dividend to its stockholders.